The method was found to be linear over the ranges investigated with r 2 values of 0.9997-0.9915 for the six drugs. The limit of quantitation for the six drugs was 0.16 to 5.12 µg, while the limit of detection was 0.08 to 2.12 µg. The intra-day and interday precision was within the ranges of 0.39 to 1.14% and 0.55 to 1.46%, respectively.
INTRODUCTION
The use of antiretroviral (ARV) drugs has resulted in a decline in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) related mortality and morbidity [1] [2] . Though the number of patients receiving antiretroviral therapy (ART) in developing countries has increased, ARVs are still not affordable and accessible to many others. Lack of wellestablished quality specifications is one of the factors that has limited recent efforts by the WHO to accelerate access to ARVs by promoting the local manufacture of quality generics through compulsory licensing under the World Trade Organization agreement on TradeRelated Aspects of Intellectual Property Rights (TRIPS) [4] . Surveys of the general quality of locally manufactured and imported generic drugs in the Kenyan market indicate a failure rate of about 10-25 % [5] [6] [7] [8] . Hence, there is need for validated methods of analysis for evaluating generic ARVs to ensure that acceptable standards of quality, safety and efficacy are achieved.
The protease inhibitors (PIs) have transformed ART as they have been shown to increase life expectancy in HIV/AIDS patients [1] [2] . The United States Food and Drug Administration has approved amprenavir, indinavir, nelfinavir, ritonavir, saquinavir, atazanavir, fos-amprenavir, tipranavir and a fixed dose combination of lopinavir/ritonavir for the treatment of HIV/AIDS patients [9] [10] [11] .
Most HIV-protease inhibitors currently in clinical use have no compendial methods of analysis (12). Different liquid chromatographic (LC) techniques for simultaneous quantification of specific combinations of PIs in biological samples have been reported [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . However, these methods have various limitations such as use of a gradient elution [14] [15] [23] [24] , long run time [15, 20, 22, 24] and use of multiple chromatographic systems per analysis [15] .
Other methods employ the rather expensive LC-MS-MS system [21] or variable wavelength detection [13] [14] [15] [16] 18 ], which may not be available in quality control laboratories in developing countries. This paper describes the development and validation of a simple, isocratic, precise and selective liquid chromatographic method for simultaneous analysis of six protease inhibitors namely amprenavir, indinavir, nelfinavir, lopinavir, ritonavir and saquinavir, using a poly(styrenedivinylbenzene) column.
EXPERIMENTAL

Chemicals and Reagents
Indinavir sulphate working standard (98.5% w/w) was from Ranbaxy Laboratories Limited (Pune, India), while saquinavir (Roche Diagnostics GMBH, Mannhelm, Germany) was a kind donation from Roche Products Limited (Nairobi, Kenya). Nelfinavir mesylate (99.9% w/w) was from Hetero Labs Limited (Hyderabad, India) and amprenavir (99.4% w/w) was obtained from GlaxoSmithKline (Nairobi, Kenya). Ritonavir and lopinavir/ritonavir capsules were from Abbott Laboratories Limited (Queenborough, U.K.).
Potassium dihydrogen phosphate (Aldrich Chemical Co. Ltd, Gillingham-Dorset, U.K.), dipotassium hydrogen phosphate (Acros Organics, Geel, Belgium), tetrabutyl ammonium hydrogen sulphate (Acros Organics Geel, Belgium) were all of analytical grade. Methanol (Fischer Scientific U.K. Ltd, Loughborough, U.K.) and tetrahydrofuran (PROLABO, Fontenay S/Bois, France) were of analytical grade and were freshly glass distilled before use. Water was freshly distilled in the laboratory.
Equipment and Materials
The liquid chromatographic system consisted of a Merck Hitachi intelligent pump model L-6200A (Hitachi Ltd, Tokyo, Japan), coupled to a 
Standard solutions
Stock solutions of indinavir, nelfinavir, saquinavir and amprenavir were prepared by dissolving appropriate amounts of accurately weighed standard substances in methanol. Stock solutions of ritonavir and lopinavir were prepared from commercial products. The stock solutions were kept at 4 °C until used. The working solution used for method development and validation was prepared by diluting stock solutions with mobile phase to a concentration of 1.0 mg/ml for indinavir and ritonavir and 0.5, 0.3, 0.2 and 1.3 mg/ml for nelfinavir, saquinavir, amprenavir and lopinavir, respectively.
RESULTS AND DISCUSSION
Method Development
Wavelength: Although the compounds under study showed highest ultraviolet absorbance at approximately 210 nm for all the compounds and also at 263 nm and 239 nm for amprenavir and saquinavir, respectively, a wavelength of 254 nm was chosen due to its versatility. There was sufficient absorbance of all compounds at 254 nm to allow analysis.
Column selection: Preliminary separation of the drugs was compared on five co-polymer columns: RoGel, PRP-1, PLRP-S 100 Å, PLRP-S 300 Å and PLRP-S 1000 Å of dimensions 250 x 4.6 mm I.D. Retention times decreased progressively from RoGel, PRP-1, PLRP-S 100 Å, PLRP-S 300 Å, and finally PLRP-S 1000 Å. The RoGel column had the lowest efficiency and high retention with only three compounds eluting within 35 min. Only three compounds were resolved on both PLRP-S 300 Å and 1000 Å columns. On the PRP-1 column, four compounds were resolved, with IDV and APV as well as RTV and LPV co-eluting. The PLRP-S 100 Å column yielded five peaks with APV and IDV co-eluting, whereas RTV and LPV were partially separated. It also gave the best column efficiency, short retention times and asymmetry factors and so it was chosen for further work.
Organic modifiers: Preliminary work was done with mobile phases consisting of organic solvent-potassium phosphate buffer (0.1 M, pH 6.0)-water (X:10:90-X, v/v). The amounts of acetonitrile and methanol required to elute the compounds were too high (50-70%). Tertiary butanol (30%) gave long retention times and could not be increased due to its high viscosity. Thirty percent tetrahydrofuran gave long retention times while 35 % gave acceptable retention times and peak separation of all the six compounds. Hence 35 % tetrahydrofuran was chosen for further work.
Effect of pH:
Variation of the pH of the potassium phosphate buffer had little effect on the retention of RTV, LPV and APV, but it had a significant effect on the retention of SQV and NFV as shown in Figure 1 . A pH of 5.0 was found to be optimal with respect to retention time and separation of the analyes. 
Effect of column temperature:
The effect of column temperature was investigated at 50, 60 and 70 °C. High back pressure and poor peak resolution were observed between RTV and LPV at 50 °C. Even though 70 °C gave better peak symmetry and improved resolution between RTV and LPV, 60 °C was preferred to avoid the unstable baseline observed at 70 °C.
Optimized conditions:
The optimal chromatographic conditions characterized by a relatively short run time as well as good resolution and asymmetry factors for all the peaks were established as: PLRP-S 100 Å 8 µm column maintained at 12 µg LPV and all the coefficients of variation were less than 20%. The coefficient of variation calculated for all the compounds at the optimal conditions ranged from 0.39 to 1.14 % for intraday and 0.55 to 1.68 % for inter-day precision. This shows that the method is reliable over a wide range of drug concentrations.
CONCLUSION
Previously reported methods for assay of various protease inhibitors recorded run times of 30-60 min and with use of gradient elution [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . The method developed in the present study offers the advantage of isocratic elution, relatively short run time and the use of a fixed wavelength detector (254 nm). Furthermore, it uses a polymer column, which is known to be more robust than silica-based columns. Therefore, the method is suitable for routine analysis of raw materials or dosage forms of the protease inhibitors singly or in combination using the same chromatographic conditions. 
